Active Site Constraint Refinement

Active Site Constraint Refinement is a computational optimization method in structure-based drug design that enhances pharmacophore models by iteratively adjusting spatial and physicochemical constraints to better align with the three-dimensional geometry and interaction preferences of a target protein's active site.

1

Publications

13

Citations

3

Authors

2

Institutions

Publications per year

2017–2026

0

Authors

3

  1. SR
    S. Roy Kimura

    Bristol-Myers Squibb (United States), United States

    1 publications · 13 citations

    1

    h-index

  2. AJ
    Andrew J. Tebben

    Bristol-Myers Squibb (United States), United States

    1 publications · 13 citations

    1

    h-index

  3. SR
    Stanley R. Krystek

    Bristol-Myers Squibb (United States), United States

    1 publications · 13 citations

    1

    h-index

1–3 of 3

Institutions

2

  1. Bristol-Myers Squibb (Germany)

    Munich, Germany

    1 h-index

    2 publications

    26 citations

  2. Bristol-Myers Squibb (United States)

    New York, United States

    1 h-index

    3 publications

    39 citations

1–2 of 2

Venues

  1. Journal of Computer-Aided Molecular Design

    1 publications · 13 citations

    1

    h-index

1–1